Why Jim Cramer Like NextEra Energy And Lincoln Electric?
On CNBC’s "Mad Money Lightning Round," Jim Cramer said NextEra Energy, Inc. (NYSE: NEE) is the "fastest growing utility." He recommended buying the stock today morning.
23andMe Pivoting To Clinical Research: Could That Lead To A Turnaround For The Stock?
Genetic testing company 23andMe Holding Co.
23andMe Announces Extension Of GSK Collaboration
GSK extends exclusive target discovery period of collaboration for a fifth year to discover and validate novel drug targets using 23andMe’s proprietary genetic and health survey database
23andMe elects for
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 445 companies made new 52-week lows.
Citigroup Maintains Neutral on 23andMe Holding, Lowers Price Target to $9
Citigroup maintains 23andMe Holding (NASDAQ:ME) with a Neutral and lowers the price target from $13 to $9.
The Daily Biotech Pulse: Valneva Inks COVID-19 Vaccine Supply Contract In Europe, I-Mab Spikes On China Deal, DermTech Sinks On Guidance
Here's a roundup of top developments in the biotech space over the last 24 hours.
Earnings Scheduled For November 10, 2021
Companies Reporting Before The Bell
• LumiraDx (NASDAQ:LMDX) is projected to report quarterly loss at $0.24 per share on revenue of $94.32 million.